Seismic Therapeutic develops machine-learning algorithms specifically designed for biologics drug discovery in the field of immunology, focusing on autoimmune diseases. Their IMPACT platform enhances the efficiency of identifying and optimizing novel therapeutic candidates, addressing the slow and costly traditional drug development processes.
Funding
$247.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional biologics drug discovery for autoimmune diseases is slow and costly, often requiring extensive screening and optimization to identify promising therapeutic candidates. The complexity of the immune system and the need for precise targeting further complicate the process.
Solution
Seismic Therapeutic is developing machine-learning algorithms to accelerate and improve biologics drug discovery in immunology, with a focus on autoimmune diseases. Their IMPACT platform leverages machine learning to enhance the identification and optimization of novel therapeutic candidates. This approach aims to create positive change in the autoimmune landscape and improve patient outcomes by streamlining the drug discovery process.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions involved in developing biologics for autoimmune diseases.
Features
- Machine-learning algorithms specifically designed for biologics drug discovery.
- IMPACT platform for efficient identification and optimization of therapeutic candidates.
- Focus on autoimmune diseases within the field of immunology.
- Development of next-generation PD 1:FcγRIIb-Selective Bifunctional Agonist Antibody (S-4321).